Pioneering phase 2 clinical trial for glioblastoma delivers initial results. While no survival breakthroughs yet, this groundbreaking adaptive platform trial brings hope for efficient therapy identification.
Breaking Ground in Cancer Research: Iron-Targeting Compounds Show Promise in Halting Cancer Cell Growth. Researchers at the University of Arizona Cancer Center unveil a potential game-changer.
Remnants of incomplete or abnormal cell division, such as micronuclei and aneuploidy, could contribute to the spread of cancer. When cells divide incorrectly, they may produce genetic material that is extruded into micronuclei, which can lead to genomic instability. This instability can result in genetic mutations, potentially promoting tumor growth and metastasis. Understanding these processes […]
Revolutionary nano-drones offer precise cancer treatment by delivering medications directly to tumor sites. These minuscule devices navigate through the body, guided by specific targeting mechanisms, and carry drugs or therapeutic agents to affected areas. This targeted drug delivery minimizes damage to healthy tissues, enhancing treatment effectiveness while reducing side effects. The nanodrones’ ability to access […]
